Sign In

Antiretroviral Therapy.

HIV Question Bank

Switching or Simplifying Antiretroviral TherapyQuestion 3/10

Questions in Topic

A 63-year-old cisgender woman who has been taking tenofovir DF-lamivudine plus darunavir-cobicistat for 3 years develops renal proximal tubule wasting, with new proteinuria, glycosuria (without evidence of diabetes mellitus), and low serum phosphate level. An HLA-B*5701 test is ordered and it is negative. The patient has no history of virologic failure or HIV drug resistance. The regimen is changed to dolutegravir-abacavir-lamivudine.

Which one of the following is expected with a change from tenofovir DF to abacavir?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 21st, 2023

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.